Most UK docs support disclosing payments from drug makers: survey
October 13, 2015
To disclose or not to disclose, that is the question.
A new survey of UK health providers finds that an overwhelming majority of those queried – 87 percent – believe that payments from drug makers should be transparent. And 69 percent who currently have a relationship with at least one drug company say they have given – or are likely to give – permission to have payment information disclosed.
Nonetheless, there is still some resistance.
Thirty-two percent believe it is unnecessary for drug makers to disclose payments to individual health care providers, and 26 percent feel disclosure will adversely affect medical innovation.
No Comment